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Abstract 
BACKGROUND: Depression in adults with type 2 diabetes can lead to non-adherence to self-
management behaviors and treatment recommendations, and ultimately worse health outcomes. 
Currently, only  50% of adult patients with type 2 diabetes treated in the primary care setting are 
screened  for depression. Without screening for depression, a diagnosis of depression and 
subsequent treatment is likely to be missed and the patient is more likely to experience worse 
health outcomes and worse quality of life.  
PURPOSE: The purpose of this study was to evaluate impact of provider education on improving 
screening rates for depression in adult patients with type 2 diabetes within the primary care 
setting. The objectives of this study were to: 1. Evaluate baseline assessment of screening rates 
using the PHQ 2/9 by providers, and provider knowledge, facilitators, and barriers regarding 
screening for depression in adult patients with type 2 diabetes in primary care; 
2. Deliver an education intervention to providers on the importance of screening adult patients 
with type 2 diabetes in the primary care setting.; and 3. Evaluate changes in depression screening 
rates using the PHQ 2/9 post educational intervention.  
METHODS:  This study used a quasi- experimental design. Phase 1 consisted of an online 
provider survey to assess knowledge, facilitators, and barriers in screening adult patients with 
type 2 diabetes for depression. Phase 2 included a provider educational intervention with pre and 
post chart reviews to assess depression screening rates.  
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RESULTS: There was a significant increase in screening from 1.9% to 6.3% (p = .024) after the 
educational intervention. Barriers to screening identified included time to screen, and knowledge 
of documentation in the EHR.   
CONCLUSION:  Providers agree that screening for depression in adult patients with diabetes is 
important and they feel  comfortable with screening. Further work is needed to identify measures 
that will continue to increase and sustain depression screening for adult patients with type 2 
diabetes in the primary care setting.    
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Introduction 
 Adult patients with type 2 diabetes are at an increased risk for depression related to the 
cost of the disease, rapidly declining health, and non-adherence to treatment regimens (Badescu 
et al., 2016). Only 50% of adult patients with type 2 diabetes seen in the primary care setting are 
properly screened and identified for depression (Egede, Walker, Bishu, & Disbuke, 2016). 
Moreover, studies have shown that adult patients with type 2 diabetes and unrecognized 
depression have increased insulin resistance and have poorer adherence to treatment 
recommendations (Ciechanowski, Katon, & Russo, 2000).  The United States spends over $21.3 
billion dollars annually in medical expenditures due to the impact of unrecognized comorbid 
depression on  adult patients with type 2 diabetes. This cost is associated with higher 
complication rates, increased use of healthcare costs, and non-adherence to treatment plans, 
which may have contributed to poor glycemic control (Egede et al., 2016). Adult patients with 
type 2 diabetes are also predisposed to other comorbidities, such as stroke, kidney disease, and 
death (Egede et al., 2016). Without properly screening adult patients with type 2 diabetes for 
depression, there is likely to be an increase in non-adherence with diabetic treatment, which may 
lead to further comorbidities and possible mortality (Badescu et al., 2016). Annual and periodic 
screening with the patient health questionnaire 2–item (PHQ-2) or 9-item (PHQ-9) version  
(PHQ-2/9) is an evidence-based strategy for addressing the problem of undiagnosed depression 
in adult patients with type 2 diabetes in the primary care setting (Kroenke & Spritzer, 2001). This 
brief screening tool is quick to implement (5 minutes or less), can be self-administered, has been 
well received by primary care providers, and has been shown to increase identification for 
depression, which can lead to better patient outcomes (Bajracharya, Summers, Amatya, & 
Deblieck, 2016). 
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       Background 
 Depression is defined as a loss of pleasure in daily activities which can lead to fatigue, 
weight loss, insomnia, psychomotor agitation, feelings of worthlessness, diminished ability to 
concentrate, and possible suicide (American Psychiatric Association, 2013). Researchers have 
found having depression can shorten one’s lifespan by 25-30 years compared to individuals who 
do not suffer from depression (Voinov, Richie, & Bailey, 2013). Type 2 diabetes is defined as a 
disease that occurs when an individual’s blood sugar is too high, and the body does not produce 
enough insulin to counteract the process (National Institute of Diabetes and Digestive and 
Kidney Disease, 2016). Globally, over 387 million people are affected by type 2 diabetes 
(Bajracharya et al., 2016). More than 30 million Americans  suffer from type 2 diabetes. In 
Kentucky, it is estimated that over 14.5% of the adult population has been diagnosed with type 2 
diabetes, and the treatment for these patients costs over $4.8 billion dollars annually (Bilous, 
2013). According to the National Institute of Mental Health, it is estimated that 17.3 million 
adults (7.1%) have been diagnosed with at least one major depressive episode (NIMH, 2017). 
Studies have shown that when a patient has a chronic illness, they are 3 times more likely to have 
co-morbid depression than the general population (Salinero-Fort et al., 2018).     
Self- management is key in creating positive health outcomes for patients with type 2 
diabetes. This often includes exercise, healthy diet, at home glucose monitoring, diabetes 
management follow ups, and emotional wellbeing. However, self-management is often minimal 
in adult patients with type 2 diabetes who suffer from comorbid depression, and this leads to 
poor health outcomes and higher medical expenditures (Mut-Vitcu et al., 2016).  Also, 
depression rates in patients with type 2 diabetes are significantly higher in uncontrolled diabetes 
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(30%), which can lead to poor self- care management (Mut-Vitcu et al., 2016). Studies have also 
shown that the moment a type 2 diabetes diagnosis is made, many patients felt stressors related 
to lifestyle changes that come with the disease, specifically diet changes and exercise (Kaltman 
et al., 2015). The emotional demands that are attached to a type 2 diabetes diagnosis can worsen 
depression, which in turn often contributes to difficulties with disease self- management 
(Kaltman et al., 2015).   
 The U.S. Preventative Services Task Force recommends screening patients for depression 
(B recommendation), especially in patients with chronic diseases such as type 2 diabetes 
(USPSTF, 2009). In addition, the American Diabetes Association recommends screening adult 
patients with type 2 diabetes during initial diagnosis of the disease, annual diabetic visits, when 
complications arise, and during hospitalizations to assess psychosocial status (AACE, 2011).  
However, despite these recommendations, depression screening in the primary care setting 
occurs for less than 5% of adult patients with type 2 diabetes (Cantor, 2018).  
A leading depression screening measure in primary care is the Patient Health 
Questionnaire (PHQ; Kroenke & Spitzer, 2001). This screening tool is composed of the PHQ 2-
item and the PHQ 9-item.  The PHQ-2, which is the initial screening, contains 2 questions to 
help providers assess a patient’s mood over the last two weeks. If the PHQ-2 is found to be 
positive, then the PHQ-9 is administered to further explore the severity of symptoms experienced 
over the preceding two-week period (Arroll et al., 2010). The PHQ 2/9 is a brief self-
administered questionnaire that has been validated as a strong indicator for identifying 
depression among adults in the primary care setting (Willborn et al., 2016).   Administering the 
PHQ-2/9 to adult patients with type 2 diabetes has been shown to improve physiological 
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outcomes such as HBA1c levels, cholesterol levels, kidney function, and hypertension by 
helping providers identify depression earlier and treat it concurrently. In addition, Willborn and 
colleagues (2016) reported that the PHQ-2/9 showed an 88% sensitivity rate in identifying and 
managing depression in adult patients with type 2 diabetes in the primary care setting. Given that 
the PHQ 2/9 is a fast, reliable, inexpensive, easily adaptable evidenced-based screening tool, all 
adult patients with type 2 diabetes should be screened in the primary care setting (Owens et al., 
2019). By utilizing the PHQ 2/9 for adult patients in primary care, type 2 diabetes and depression 
can be treated concurrently, and this may prevent further comorbidities and mortality. 
The PHQ 2/9 screening tool is located on the organization’s electronic health record (EHR) 
where this study was performed as an accessible flow sheet, which can be easily added to the 
patient encounter by a smart phrase. Unfortunately, there is no current protocol in place at this 
primary care location to make sure screening with the PHQ 2/9 occurs in adult patients with type 
2 diabetes, despite recommendations. If screenings occurred in the office prior to this study, they 
were conducted in the following manner: 1. The provider would administer the PHQ 2/9 to the 
patient through the (EHR during the patient visit, or ;2. The medical assistant (MA) would give a 
paper copy to the patient to complete during rooming and the provider would discuss the results 
during the visit and document the score in the EHR.  
 
        Purpose 
The main purpose of this study was to evaluate the relationship between provider 
education about the PHQ 2/9 and screening rates for depression in adults with type 2 diabetes in 
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a primary care setting. An additional purpose was to gain an understanding of why depression 
screenings were not being completed on adult patients with type 2 diabetes in this setting and 
implement and evaluate an intervention to improve it.   
The specific aims of the project were:  
1. Describe a baseline assessment of depression screening rates using the PHQ 2/9 by providers, 
and assess provider knowledge, facilitators, and barriers to screening for depression in adult 
patients with type 2 diabetes in primary care.   
2. Evaluate the impact of an educational intervention for providers on the importance of 
screening adult patients with type 2 diabetes for depression, by comparing PHQ 2/9 screening 
rates both pre- and post-intervention. 
        Methods 
This project used a quasi-experimental study design to describe provider knowledge, 
perceptions, and barriers related to depression screening and to evaluate depression screening 
rates before and after an educational intervention for providers. This study consisted of three 
phases.   
  Phase 1: Retrospective Chart review/Provider Survey 
This phase included a retrospective chart review to assess baseline screening rates to 
assess whether adult patients with type 2 diabetes were screened for depression using only the 
PHQ 2/9. In addition, an anonymous electronic survey was sent to assess providers’ knowledge 
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of the PHQ 2/9 questionnaire along with facilitators and barriers in screening adult patients with 
type 2 diabetes for depression.  
Phase 2: Provider Educational Intervention 
  This phase included an educational intervention for providers, delivered during a lunch 
and learn session which also included sharing of phase 1 baseline screening rates and provider 
survey results. Providers were also invited to share their on knowledge and perceived barriers 
regarding screening. 
Phase 3: Retrospective Chart Review 
This phase included a post educational intervention retrospective chart review to 
determine if screening rates increased using the PHQ 2/9 questionnaire for adult patients with 
type 2 diabetes.  
Theoretical Framework  
The theoretical framework that informed the design of this study was Dorothea Orem’s 
self-care nursing theory. The goal of Orem’s theory is to help create a strong patient provider 
relationship, and for the patient to control or minimize the effects of poor chronic health by 
understanding health deviation self-care requisites that can result from chronic illnesses such as 
type 2 diabetes (Gonzalo, 2019). Since adult patients with type 2 diabetes are at an increased risk 
for developing depression, providers need to be able to identify and treat depression for the 
patient to achieve and/or maintain good mental and physical health. This will help the patient 
adapt to pathologic changes that often occur with chronic illnesses such as type 2 diabetes. 
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Setting 
The setting for all phases of this study was an outpatient primary care office that is part of 
a large healthcare organization in the Midwest. Annually, the office is responsible for the 
management and treatment of approximately 4800 adult patients with type 2 diabetes in 
Louisville, Kentucky and the surrounding area. At the time of this project, there were seven 
providers in the office, which included two nurse practitioners and five physicians.  
Sample 
The medical record numbers for phases 1 and 3 of this study were obtained from the 
healthcare organization’s data analytics team. A request was made to include eligible medical 
records with the following inclusion/exclusion criteria. Inclusion criteria encompassed: 1.) Male 
and female patients over the age of 18 presenting for annual wellness visits or diabetes 
management visits; 2.) male and female patients with ICD-10 diagnosis of Type 2 Diabetes 
Mellitus (E11.9) at the study site. Exclusion criteria included: 1.) All patients under the age of 18 
years of age; 2.) patients with Type 1 or Gestational Diabetes; 3.) patients with single ICD-10 
diagnosis of depression (F41.8); 4.) patients with the ICD-10 code of type II diabetes (E11.9) 
along with other comorbidities (ex; hypertension, and hyperlipidemia); and 5.) patients not seen 
at the chosen study site.  Eligible medical records were then selected by the statistician by simple 
random sampling and returned to the principal investigator (PI) for phases 1 and 3 of the study.  
For the survey, the PI collected study site provider names from the organization’s HR 
department. The survey (see Appendix B) included four yes or no, one Likert-style, and three 
multiple choice questions that assessed providers’ perceptions of their knowledge of, and barriers 
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to using the PHQ 2/9 in the clinical setting. The survey took approximately 5-10 minutes to 
complete. The reliability and validity of the survey has not been determined, as it was generated 
by the PI and not trialed prior to this study.   
Procedures 
This study occurred in three phases at one primary care office setting. Data were  
collected to assess current screening rates and knowledge of providers who use the PHQ 2/9 in 
adult patients with type 2 diabetes.  
Phase 1: Retrospective chart review 
For the retrospective chart review, 215 charts that met eligibility requirements were 
audited from the study site, in order to determine baseline provider documentation of depression 
screening using the PHQ 2/9 between July 1, 2018 and July 1, 2019. The results of the chart 
review were provided in phase 2 during the educational intervention. 
Regarding the provider survey, an email was sent to all seven providers at the study site 
with a cover letter (see Appendix A) and link that would take them directly to a survey (see 
Appendix B).  The survey was given through an online service, REDCAP (Harris et al., 2019). 
Participants were given a two-week window to complete the survey. The results of the survey 
were anonymous and exported via Microsoft Excel through REDCAP; then they were analyzed 
by a statistician.  
The University of Kentucky Institutional Review Board granted approval (#46927) prior 
to the start of the project. Permission was granted to obtain work email addresses for the specific 
providers at the chosen site of study to send the cover letter (see Appendix A) and survey (see 
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Appendix B). The cover letter explained the PI’s goals for the study and benefits to screening 
patients with type 2 diabetes for depression. Responses to the survey were anonymous and data 
collection was performed via REDCAP. The results from the survey were provided in phase 2 
during the provider education intervention.  
Phase 2: Education Intervention and Focus Group 
The educational intervention was conducted two weeks after completion of the baseline 
provider survey, on August 21, 2019. Topics included baseline screening rates and an aggregate 
summary of survey responses. The intervention also focused on re-educating providers on how to 
use the PHQ 2/9 questionnaire, why it is important to screen adult patients with type 2 diabetes 
for depression, accessibility of the PHQ 2/9 in the EHR, and how to document the scores in the 
EHR during the patient visit. The educational session lasted ten minutes. Education was given to 
providers who were present that day using a PowerPoint presentation during a scheduled lunch 
break where food was provided (see Appendix C). Permission was obtained prior to the 
intervention for the primary investigator to attend a regularly scheduled provider meeting 
following IRB approval. Providers who were unable to attend received a copy of the information 
that was discussed during the presentation and were given the PI’s phone number in case 
questions arose.  
Providers who attended the educational session were asked to begin or continue utilizing 
the PHQ 2/9 questionnaire for eligible patient visits. During the focus group meeting with 
providers, a review of how to use the PHQ 2/9 questionnaire and where to document results in 
the EHR was discussed. The importance of identifying depression earlier in adult patients with 
type 2 diabetes by using the PHQ 2/9 was also discussed. Results from the Phase 1 chart review 
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and survey were reviewed with providers. Providers were given the opportunity to discuss 
barriers to screening eligible adult patients with type 2 diabetes using the PHQ 2/9 questionnaire. 
The PI took notes during the conversation. 
Phase 3: Retrospective Chart Review  
Phase three consisted of a retrospective chart review that occurred four weeks post 
educational intervention (08/21/2019-09/21/2019) to determine if depression screening rates 
increased in adult patients with type 2 diabetes. The data analytics team from the healthcare 
organization helped to compile a list of eligible charts that met the inclusion and exclusion 
criteria and 215 charts were reviewed. All seven providers were included in the post education 
audit chart review since four of the providers were present for the educational intervention, and 
the other three received a copy of the PowerPoint slides (see Appendix C) for review. Audit tools 
were used in both chart reviews to ensure consistency, then destroyed per guidelines. 
Data Analysis 
Descriptive statistics were used to summarize the variables such as age, gender, ethnicity, 
insurance use, PHQ 2/9 results, and the provider survey responses using Microsoft Excel to 
create tables with percentages.  Screening rates for using the PHQ 2/9 questionnaire were also 
examined pre and post educational intervention using the chi-square test of association using 
SPSS, version 25, with an alpha of <.05.  Focus group responses were written down by the PI 
and categorized into themes.  
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Results 
PHASE 1: BASELINE CHART REVIEW  
Patients on average were Caucasian (94%, n=202) females (53%, n=114) over the age of 
65 (47%, n=101) and had Medicare insurance (46%, n=100; see Table 2).  The data research 
query returned over 26,317 eligible medical records and 215 charts were randomly selected by 
choosing every fifth  one until a sufficient sample size was obtained. The charts were reviewed to 
determine if providers were screening adult patients with type 2 diabetes for depression using the 
PHQ 2/9 questionnaire. For the score to be counted in the audit, the PHQ 2/9 questionnaire score 
needed to be visible in the patient’s visit encounter summary. Of the 215 randomly selected 
charts, only four (1.9% see table 1) were found to have been screened with the PHQ 2. Patients 
who were identified as being positive for screening were on average Caucasian (100%, n=4) 
males (50%, n=2) and females (50%, n=2) over the age of 65 (75%, n=3) with Medicare 
insurance (75%, n=3; see table 3). Of the four patients that were screened, three were found to be 
negative for depressive symptoms and one was found to be positive.  
PHASE 1: PROVIDER SURVEY 
The provider survey (see Appendix B) assessing knowledge, facilitators and barriers to 
using the PHQ 2/9 was sent to seven providers at one primary care office. Out of the seven 
providers, four returned their responses anonymously through REDCAP (see Table 4). Providers 
stated they were familiar with the PHQ, mostly familiar with wear to access and document in the 
EHR, they sometimes screen patients, agree that it is important to screen, they feel confident in 
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screening with a comfort level mean of 8.3, but time was their biggest barrier in screening 
patients. 
 
 
PHASE 2: FOCUS GROUP RESULTS  
After the education was presented, providers were afforded the opportunity to share their 
feedback regarding the PHQ 2/9 questionnaire. Four providers were present and identified time 
as the biggest barrier in performing the PHQ 2/9 for adult patients with type 2 diabetes. The 
providers stated they were knowledgeable and confident in screening but were overwhelmed 
with high patient loads, which they felt contributed to missed screenings. Since responses to the 
provider survey were anonymous for phase 1, there was no way to identify whether the providers 
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who attended the focus group were the same ones that filled out the provider survey. There was 
no mention of lack of knowledge as a barrier during the focus group. 
PHASE 3: RETROSPECTIVE CHART REVEW 
Patients included in the post-intervention chart audit were most likely to be Caucasian 
(85%, n=149) males (50.3%, n=88) between the ages of 55-65 (36%, n=63) with private 
insurance (61%, n=107; see table 5). The second data research query returned over 2,154 eligible 
medical records that met criteria for the retrospective chart review post education intervention 
for phase 3 (see Appendix C). There were 175 medical records chosen randomly by picking 
every 5th one until a sufficient sample size was obtained. The charts were reviewed to determine 
if providers were screening adult patients with type 2 diabetes for depression using the PHQ 2/9 
questionnaire. For the score to be counted in the audit, the PHQ 2/9 questionnaire score needed 
to be visible in the patient’s visit encounter summary.  Patients who were identified as being 
positive for screening on average were Caucasian (73%, n=8) females (82%, n=9) ages 55-65 
(46%, n=5), and had private insurance (73%, n=8; see table 6).  Of the 175 charts reviewed, 11 
patients (6.3%; see Table 1) were screened using the PHQ. Of the 11 patients that were screened, 
six patients were found to be negative for depression using the PHQ 2, and five were positive 
and then followed up with the PHQ 9 to determine the severity of depressive symptoms.  
After the educational intervention, providers were more likely to agree that screening is 
important and to feel comfortable screening with the PHQ 2/9 questionnaire (mean score 8.3; see 
Table 4). There was a significant increase in screening from 1.9% to 6.3% (p = .024; see Table 1) 
after the educational intervention. Barriers to screening included time, which was consistent with 
the main barrier identified in phase 1. 
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           Discussion 
The purpose of this study was to describe a baseline assessment of depression screening 
rates using the PHQ 2/9, and assess provider knowledge, facilitators, and barriers to screening 
for depression in adult patients with type 2 diabetes in a specific primary care clinic. Second, to 
evaluate the impact of an education intervention for providers on the importance of screening 
adult patients with type 2 diabetes for depression in the primary care setting. Depression 
screening rates increased from 1.9% to 6.3% (see Table 1), and time was identified as the most 
significant barrier to screening both pre and post intervention. The finding of low screening rates 
is consistent with the national average of 5% (Cantor, 2018), but it is encouraging that this clinic 
increased screening rates from 1.9% to 6.3% (see Table 1), which now exceeds the national 
average. However, 6.3% is still very low and additional strategies to improve depression 
screening rates are still very much needed, both in this setting and nationally. 
The provider participants in this study all had good baseline knowledge scores and 
positive perceptions about the importance of screening for depression in adults with type 2 
diabetes, which suggests that they are willing and able to complete the depression screening. 
However, time to screen appears to be a significant barrier that needs to be addressed for the 
providers in this setting. This is also a national problem, as evidenced by the fact that other 
researchers have also found time to be the biggest barrier to screening (Colligan et al, 2018; 
Sanchez, Eghaneyan,  & Trivedi, 2016). Thus, an important finding from this study is the 
recognition of time as a major barrier that needs to be addressed in this setting.  
There are a variety of evidence-based strategies that have helped improve depression 
screening rates in primary care settings and the use of information technology (IT) is a leading 
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approach. Use of IT to facilitate depression screening in the primary care setting where this study 
took place would be particularly helpful, as it addresses the barrier of time, provides a 
standardized place to document, and initiates provider alerts (Savoy & O'Gurek, 2016; Triveti et 
al., 2019). Other evidence-based strategies include empowerment of staff, which includes having 
the medical assistant (MA) provide a paper copy of the PHQ for the patient to complete  while . 
This will decrease the time it takes to screen for providers and staff and give the patient 
something to do while waiting to see the provider. Patients with access to their patient portal 
could be asked to complete the questionnaire electronically prior to their visit (Savoy & 
O’Gurek, 2016; Triveti et al., 2019).  
These are strategies to consider implementing in this setting as a next step. The increase 
in screening rates after the provider education suggests that this session may have led to the 
increase in depression screening. Although this study was not designed to test for causation, it is 
encouraging that there was a significant improvement in screening after a brief and simple 
session with the providers. Because baseline knowledge scores were already high and 
perceptions started out positive, it does not seem likely that the providers learned new 
information; however, it is possible that simply discussing depression screening brought it to the 
forefront of their attention and thus made them more likely to screen. In addition, providers were 
very engaged during the focus group when reminded of how to document via smart text phrase in 
the EHR.  Further investigation is needed to determine what specific element of the educational 
intervention led to this improvement. Brief education to providers may have played a major role 
with the increased screening rates. Studies have shown that efforts such as education to 
providers, consistent depression management and follow up, and a collaborative care approach 
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can increase depression screening rates in the primary care setting (Maimone & Marhatta, 2015; 
Unützer  & Park, 2012).  Further research to assess depression screening for all adults in the 
same age group would lend attention to the need for screening.  
The increase in depression screening rates is a positive and encouraging finding from this 
study; however, the screening rates are still very low and evidence-based strategies to sustain this 
improvement and improve screening even more are needed. Effective sustainment strategies that 
have worked well in other settings and would be appropriate in this study’s setting include the 
use of performance metrics and reporting mechanisms (Schaeffer & Jolles, 2019; Kroenke & 
Unutzer, 2017). This can often include strategies such as the use of scorecards or monthly 
provider audits by an appointed team leader in the clinic.  
Implications for Practice 
 Time was identified by the providers as the biggest barrier to screening, so implementing 
strategies to reduce the time burden is an important next step for this clinic as well as other 
clinics.   An evidence-based strategy that should be considered for practice is training and 
empowerment of staff to help streamline the process (Savoy & O’Gurek, 2016). Since one 
provider in the baseline chart audit screened a patient positive using the PHQ 2 but did not 
follow up with the PHQ 9 per recommendations, further training needs to occur with providers. 
Future practice should include continued education for providers on the importance of screening 
adult patients with type 2 diabetes for depression using the PHQ 2/9 (Maimone &Marhatta, 
2015; Unützer & Park, 2012). One way to remind providers how the screening process with the 
PHQ2/9 works is to place posters and prompts in the office rooms (Schaeffer, & Jolles, 2019).  
Another beneficial method would be for the MA to give the patient a paper copy of the PHQ 2/9 
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screening tool to complete while rooming, then place scores in the EHR for the provider to 
discuss with the patient. This is an efficient use of time and a collaborative approach that does 
not overburden the patient, provider or staff (Savoy & O’Gurek, 2016).    
If the EHR has the capability, it would be ideal to initiate a best practice advisory alert for 
all adult patients with type 2 diabetes to ensure they are screened during annual visits and follow 
ups (Savoy & O'Gurek, 2016; Kroenke, 2017). Additionally, for patients with access to the 
patient portal, another implication for future practice would be the use of Mychart, which 
provides access to their medical records and already in use within  the organization. This could 
serve as a means for the patient to fill out the PHQ 2/9 questionnaire prior to the scheduled visit. 
This allows the provider to already have the scores in the EHR to discuss during the patient 
encounter. The responses would be available on the vital sign screen and the provider can carry 
over the results into the patient encounter summary (Savoy & O’Gurek, 2016; Triveti et 
al.,2019). 
  It would also be worthwhile to implement a tracking measure to monitor screening 
adherence (Kroenke & Unutzer, 2017).  According to a prediction made by the World Health 
Organization, by the year 2030 depression rates will double and be the leading cause of life lost 
due to disability (El-Hechmi et al., 2013). It is imperative for primary care offices to ensure that 
they screen all adult patients with type 2 diabetes for depression along with proper follow up and 
management, to help ensure the patient is being treated both mentally and physically. 
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Limitations 
 Limitations of this study included a small sample size of providers who responded to the 
survey (N=4) out of a total of seven possible.  In addition, only four out of a total of seven 
providers attended the focus group. Since the surveys were anonymous, there was no way to 
determine if the  providers that attended the focus group (N=4)were the same providers  that 
responded to the survey (N=4). In addition, this study took place at only one clinic over a period 
of a few months.  Increasing the study reach to include multiple locations could increase the 
number of providers who participate in the survey. The post chart review audit may have been 
higher if multiple sites  were included.    
    Conclusion 
Patients with diabetes are 30% more likely to be depressed than the general population 
(Mut-Vitcu et al., 2016), and depression leads to worse self-management and health outcomes. 
However, depression screening rates among adults with diabetes are very low, at only 5%. 
Because of the impact on health outcomes and quality of life, providers must do a better job of 
screening in order to identify and treat depression appropriately. The PHQ 2/9 is a brief, self-
administered questionnaire that has been validated for identifying depression among adults in the 
primary care setting (Kroenke & Spritzer, 2001).  Patients may only see their primary care 
provider every 3-6 months, so screening at these visits is important so depression can be 
identified and addressed if indicated; ;otherwise, the negative effects are likely to continue as the 
patient goes untreated.  Earlier identification of depression can lead to better diabetes 
management, improve morbidity and mortality and help lower medical expenditures when 
patients are treated for type 2 diabetes and depression concurrently.   In this study, after a brief 
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education session for providers that focused on why and how to screen and where to document 
the screening, there was an increase in depression screening rates for adult patients with type 2 
diabetes. However, screening rates were still low and there remains much need for improvement. 
Future work should seek to identify which specific elements of this intervention contributed to 
the success and strategies to ensure sustainability of these improvements should be explored.  
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Table 1. Screening rates for Depression  
 
 Pre- education 
n (%) 
Post-education 
n (%) 
              p 
Screened  4 (1.9%)  11 (6.3%) .024 
Not Screened  211 (98.1%) 164 (93.7%)  
 215 175  
 
 
 
Table 2. Pre education chart review Demographics (N=215) 
 
 
Gender 
Male 
Female 
 
101 
114 
 
47% 
53% 
Age 
18-24 
25-34 
35-44 
45-54 
55-65 
>65 
 
0 
3 
14 
35 
62 
101 
 
0% 
1% 
7% 
16% 
29% 
47% 
Race 
Caucasian 
African American 
Hispanic 
Asian 
 
202 
11 
1 
1 
 
94% 
5% 
.5% 
.5% 
Insurance 
Private 
Medicare 
Medicaid 
 
96 
100 
19 
 
45% 
46% 
9% 
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Table 4. 
 
Table 3. Phase 1 chart review results demographics (N=4) 
Gender 
Male 
Female 
 
2 
2 
 
50% 
50% 
Age 
18-24 
25-34 
35-44 
45-54 
55-65 
>65 
 
0 
0 
1 
0 
0 
3 
 
0% 
0% 
25% 
0% 
0% 
75% 
Race 
Caucasian 
African American 
Hispanic 
Asian 
 
4 
0 
0 
0 
 
100% 
0% 
0% 
0% 
Insurance 
Private 
Medicare 
Medicaid 
 
1 
3 
0 
 
25% 
75% 
0% 
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Table 5. Post education chart review Demographics (N=175) 
Gender 
Male  
Female 
 
88 
87 
 
50.3% 
49.7% 
Age 
18-24 
25-34 
35-44 
45-54 
55-65 
>65 
 
0 
4 
10 
42 
63 
56 
 
0% 
2% 
6% 
24% 
36% 
32% 
Race 
Caucasian 
African American 
Hispanic 
Asian 
 
149 
21 
0 
5 
 
85% 
12% 
0% 
3% 
Insurance 
Private 
Medicare 
Medicaid 
 
107 
56 
12 
 
61% 
32% 
7% 
 
 
Table 6. Post education chart review results demographics (N=11) 
Gender 
Male 
Female 
 
2 
9 
 
18% 
82% 
Age 
18-24 
25-34 
35-44 
45-54 
55-65 
>65 
 
0 
1 
1 
4 
5 
0 
 
0% 
9% 
9% 
36% 
46% 
0% 
Race 
Caucasian 
African American 
Hispanic 
Asian 
 
8 
3 
0 
0 
 
73% 
27% 
0% 
0% 
Insurance 
Private 
Medicare 
Medicaid 
 
8 
0 
3 
 
73% 
0% 
27% 
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Appendix A 
Dear Providers at chosen site of study, 
You are being invited to participate in a research study, “Evaluation of Depression Screening by 
Primary care providers who provide care for Adult Patients with Type II Diabetes Mellitus”.  
The purpose of this study will be to assess baseline screening rates in providers who screen for 
depression in the adult type II diabetic population. Furthermore, the purpose will be to educate 
providers about the benefits of identifying depression using the PHQ 2/9 screening tool and 
treating it concurrently with type II diabetes. The focus group for this study will be providers and 
those who treat adult patients with type II Diabetes Mellitus in the primary care setting.  
The Principal Investigator is Kristy Bryant who is a student in the Doctor of Nursing Practice 
Program at the University of Kentucky College of Nursing and current employee at the chosen 
site of study.  
Your participation in this study is entirely voluntary.  If you agree to participate in the study, you 
will be asked to complete an online survey on REDCAP that asks you to provide answers to 8 
questions, in the form of YES or NO, Likert Scale, and multiple choice. The survey should only 
take 5-10 minutes to complete.  
An educational session will follow 1-2 weeks after completion of the survey in phase 2 of this 
study. Education will be provided on the importance of utilizing the PHQ 2/9 screening tool, 
where to find and document the tool in EPIC, and why we need to screen Type II Diabetics for 
depression. The educational session will also include survey results to discuss knowledge, 
facilitators and barriers to using the PHQ 2/9 screening tool in the primary care setting.   The 
study will take place from May 1, 2019 to October 1, 2019.  There is no risk to participate in the 
study.  
The benefits that may be derived from this research include; that with future improvement of 
depression screening in adults with type II diabetes mellitus, individuals who have not been 
previously recognized or screened for depression will be identified as screening process 
improvement takes place. Earlier identification of depression in chronic diseases such as type II 
Diabetes Mellitus is associated with decreased comorbidities and mortality associated with the 
disease, decreased health care expenditures, and improved quality of life.  
We make every effort to safeguard your data once received on our servers via REDCAP.  Given 
the nature of online surveys, as with anything involving the internet, we can never guarantee the 
confidentiality of data still en route to us. REDCAP is a secure, web-based application designed 
exclusively to support data capture for research studies.  Your responses will be anonymous. 
Records of your participation in this study will be kept confidential to the extent permitted by 
law. Results of this research will be reported as summarized data and will not contain any 
identifiable individual data. 
Should you have any questions you may contact Kristy Bryant, the Principal Investigator, at 
kmbu253@uky.edu. If you have complaints, suggestions, or questions about your rights as a 
research volunteer, contact the staff in the University of Kentucky Office of Research Integrity at 
859-257-9428 or toll-free at 1-866-400-9428.Your completion of the survey will be considered 
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your consent to participate in the study and as your agreement that you have been sufficiently 
informed of the purpose of the study and any risks and benefits. If you agree to participate in the 
study, please click on the below link to access the survey. 
https://redcap.uky.edu/redcap/surveys/?s=E3TPEDHTJJ 
Thank you in advance for your assistance with this important project.   
Sincerely, 
Kristy Bryant College of Nursing, University of Kentucky  
DNP Student 
 E-MAIL: kmbu253@uky.edu 
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Appendix B  
Evaluation of Depression Screening by Providers for Adult Patients with type II diabetes mellitus 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) Are you familiar with the PHQ 2/9 screening 
tool for Depression?   
Yes 
No  
2) Do you know where to access the PHQ 2/9 
screening tool to administer to your patients?   
Yes 
No  
3) Do you know where to document the PHQ 2/9 
screening scores in EPIC?   
Yes 
No  
4) How often do you use the PHQ 2/9 screening 
tool on your Type II Diabetic patients  
5) Do you feel that it is important to screen adults 
with Type II Diabetes for Depression?   
6) Do you feel confident in scoring patients using 
the PHQ 2/9 screening tool?   
Yes 
No  
7) On a scale of 1-10 (with 1 being not comfortable 
at all and 10 being completely comfortable), 
how do you rate your comfort level in using the 
PHQ 2/9 in screening patients for depression?   
1  2  3  4
 5  6  7  8  9  10  
8) What barriers do you feel prevent you from 
performing the PHQ 2/9 screening for 
depression on your adult patients with type II 
diabetes? Fill in the blank   
Time  Importance 
of PHQ  Knowledge of PHQ  Other  
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